$3.53
+0.13 (+3.82%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+445.0% upside
Low Target
$16.83
Average Target
$19.24
High Target
$29.48
Current Price
$3.53
Current
$3.53
$3.53
Target
$19.24
$19.24
$16.83
$19.24 avg
$29.48
Scenario Analysis
Bear Case
$16.83
376.8%
Low target
Base Case
$19.24
+445.0%
Avg target
Bull Case
$29.48
+735.1%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$25.40
-86.1% from high
52-Week Low
$16.55
+-78.7% from low
Target vs 52W High
$19.24
-24.3% vs high
Next Earnings Report
Feb 26, 2026 · After Market Close
9d
until earnings
EPS Est: $-0.13
Earnings in 9 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 37 | 68% | $257.58 | +15.3% |
| AMGN | Hold | 41 | 54% | $190.87 | -50.3% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.8% |
| VRTX | Strong Buy | 39 | 77% | $438.34 | -8.3% |
| REGN | Strong Buy | 36 | 75% | $76.80 | -90.2% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -68.8% |
| INSM | Strong Buy | 27 | 93% | $143.40 | -4.3% |
| BIIB | Hold | 42 | 48% | $91.45 | -54.5% |